|
|
|
By Vishal Mehta, Founder & CEO, Ubuntu Research | This article explores the rapid evolution of cell and gene therapy (CGT), highlighting its expansion beyond hematology and oncology into autoimmune and metabolic diseases, emphasizing the need for safety, patient access, and a collaborative, knowledge-sharing approach to accelerate innovation and ensure broader therapeutic impact via the "Knowledge Research Organization." | |
|
|
| Gene Therapy In Neurology: The Case For Optimism | White Paper | TFS HealthScience | Advancements in genetic therapy are revolutionizing the treatment of neurological diseases, with promising results from preclinical studies leading to clinical trials focused on safety and efficacy. |
|
|
|
|
| The High Cost Of CRO Turnover (And How You Can Avoid It) | Article | By Ben Edwards and Liz Hawes, Avance Clinical | Though some turnover is an inevitable part of a business’s life cycle, there are several strategies available to ensure a consistent CRO team throughout the span of your trial. |
|
|
| How FAIR Data Principles Deliver Clinical Success | Article | By Philip Ross, Revvity Signals Software, Inc. | Prioritize data management that adheres to FAIR principles — findable, accessible, interoperable, and reusable — to gain operational insights that enable quick decisions and ensure participant well-being. |
|
|
|
CLINICAL TRIALS SOLUTIONS |
|
|
|
|
|
|
|
By Jennifer Chain, Ph.D., CABP, Consultant, CSM Consulting LLC | Advanced cell-based therapies are impossible without high-quality leukopaks from high-quality donors. | |
|
|
| 4 Ways To Safeguard Your Supply Of Fetal Bovine Serum | Article | Corning Life Sciences | A fetal bovine serum shortage would have significant repercussions throughout the life sciences industry. However, there are a few steps FBS users can take now to secure their supply chain. |
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
